Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
von Kieseritzky, K. Aktuelles zu GIST: Imatinib ist Standard im metastasierten Stadium. Info Onkol. 16, 44 (2013). https://doi.org/10.1007/s15004-013-0678-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15004-013-0678-9